Pediatric Case Reports|Articles in Press

Safety and Efficacy of Long-Acting Liposomal Bupivacaine Plus Bupivacaine Hydrochloride for Dorsal Penile Block During Ambulatory Pediatric Urologic Surgery

      This study evaluates the tolerability and efficacy of preoperative dorsal penile nerve block with Exparel plus bupivacaine hydrochloride in children>6 years old undergoing ambulatory urologic surgery. We demonstrate that the drug combination is well-tolerated, with appropriate analgesic efficacy in the recovery room as well as at 48-hour and 10-14 day follow-up periods. These preliminary data justify the need to perform a prospective, randomized trial comparing Exparel plus bupivacaine hydrochloride to other common local anesthetic regimens used in pediatric urologic surgery.


      Exparel (Liposomal bupivacaine), PACU (Post-anesthesia care unit), FLACC (Face, legs, activity, cry, consolability), PPPM (Parents' postoperative pain measure), NPS (Numerical pain score), OMEQ (Oral morphine equivalents)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Stamenkovic D.M.
        • Bezmarevic M.
        • Bojic S.
        • et al.
        Updates on wound infiltration use for postoperative pain management: a narrative review.
        J Clin Med. 2021; 10: 4659
        • Joshi G.
        • Gandhi K.
        • Shah N.
        • Gadsden J.
        • Corman S.L.
        Peripheral nerve blocks in the management of postoperative pain: challenges and opportunities.
        J Clin Anesth. 2016; 35: 524-529
        • Tirotta C.F.
        • de Armendi A.J.
        • Horn N.D.
        • et al.
        A multicenter study to evaluate the pharmacokinetics and safety of liposomal bupivacaine for postsurgical analgesia in pediatric patients aged 6 to less than 17 years (PLAY).
        J Clin Anesth. 2021; 75110503
      1. Pacira Biosciences. Pacira announces FDA approval of supplemental new drug application for Exparel® (Bupivacaine liposome injectable suspension) in pediatric patients. 〈〉.

        • Schröder A.
        • Campbell F.A.
        • Farhat W.A.
        • et al.
        Postoperative pain and analgesia administration in children after urological outpatient procedures.
        J Pediatr Urol. 2018; 14: 171.e1-171.e6
        • King S.A.
        • Gonzalez J.R.
        • Goldstein I.
        141 Use of dorsal nerve block with bupivacaine liposome injectable suspension (Exparel) for pain management following Three-Piece Penile Prosthesis Surgery.
        J Sex Med. 2016; 13: S66
      2. Dosing-Administration Instructions for Exparel(R) in Pediatric Patients. Pacira Biosciences Inc. 〈〉.

        • Horton J.D.
        • Munawar S.
        • Corrigan C.
        • White D.
        • Cina R.A.
        Inconsistent and excessive opioid prescribing after common pediatric surgical operations.
        J Pediatr Surg. 2019; 54: 1427-1431
        • Carolan A.M.C.
        • Parker K.M.
        • Grimsby G.M.
        Opioid use after pediatric urologic surgery: is it really needed.
        Urology. 2021; 158: 184-188
        • Hamilton T.W.
        • Knight R.
        • Stokes J.R.
        • et al.
        Efficacy of liposomal bupivacaine and bupivacaine hydrochloride vs bupivacaine hydrochloride alone as a periarticular anesthetic for patients undergoing knee replacement: a randomized clinical trial.
        JAMA Surg. 2022; 157: 481-489